OxyContin maker Purdue Pharma LP spent years constructing a restructuring plan to settle 1000’s of lawsuits and ship funding to fight the opioid disaster. That plan is in limbo after a federal choose dominated {that a} deal the corporate struck with its house owners isn’t allowed underneath the regulation.
After U.S. District Choose Colleen McMahon’s shock ruling final week overturning a roughly $4.5 billion settlement between the OxyContin maker and members of the Sackler household who personal the corporate, Purdue, as soon as on the verge of settling an onslaught of lawsuits over its flagship opioid painkiller, will stay in chapter court docket because it makes an attempt to salvage a settlement that took years and tons of of hundreds of thousands of {dollars} to craft.